Artemisinin and its derivatives have shown broad-spectrum antitumor activities in vitro and in
vivo. Furthermore, outcomes from a limited number of clinical trials provide encouraging …

Qinghaosu, known as artemisinin (ARS), has been for over two millennia, one of the most
common herbs prescribed in traditional Chinese medicine (TCM). ARS was developed as …

Chemotherapy‐induced cognitive impairment (“chemobrain”) is a frequent side‐effect in
cancer survivors treated with paclitaxel (PTX). The mechanisms responsible for PTX …

Purpose To investigate the role of EGFR and STAT3 in breast cancer development and
progression. Methods Through bioinformatics analysis differently expressed genes (DEGs) …

Dihydroartemisinin (DHA) has been globally recognized for its efficacy and safety in the
clinical treatment of malaria for decades. Recently, it has been found that DHA inhibits …

Combination therapy emerges as a fundamental scheme in cancer. Many targeted
therapeutic agents are developed to be used with chemotherapy or radiation therapy to …

Cancer is the leading cause of human death which seriously threatens human life. The
antimalarial drug artemisinin and its derivatives have been discovered with considerable …

Cancer, malaria, and leishmaniasis remain the deadly diseases around the world although
several strategies of treatment have been developed. However, most of the drugs used to …

Cancer is one of the major threats to human health. Although humans have struggled with
cancer for decades, the efficacy of treatments for most tumors is still very limited …

Non-small cell lung cancer (NSCLC) is the most common malignancy worldwide. A
significant fraction of NSCLC carries activating mutations in epidermal growth factor receptor …